Effects of FES-Rowing in Paraplegia (FES-ROW)

Sponsor
UGECAM Rhône-Alpes (Other)
Overall Status
Recruiting
CT.gov ID
NCT04821635
Collaborator
University of Franche-Comté (Other), Hospices Civils de Lyon (Other), University of Lyon (Other)
35
2
1
24
17.5
0.7

Study Details

Study Description

Brief Summary

The main objective of this project is to measure the increase in aerobic physical and metabolic capacities with a 6-month training on a rower assisted by electrostimulation of lower limbs in a population of adults with traumatic paraplegia.

Condition or Disease Intervention/Treatment Phase
  • Device: Rower assisted by electrostimulation (FES-ROW)
N/A

Detailed Description

Beyond the inability to walk, chronic paraplegic patients show an increase in their mortality from cardiovascular pathologies, compared to the same age groups of the general population. It is the hypoactivity induced by neurological impairment that is implicated in the first place in the pathogenesis of these abnormalities. The search for training methods adapted to these patients is justified to limit cardiovascular morbidity and mortality.

The aim of this project is to measure the increase in aerobic physical and metabolic capacities with a 6-month training on a rower assisted by electrostimulation of lower limbs in a population of adults with stabilized paraplegia (non-walkers), of traumatic origin.

Study is divided in two 3-month phases. The first consists on a training on a rowing machine with solicitation of the electrostimulated lower limbs only for a period of 3 months at the rate of 3 sessions of 30 minutes per week. The second consists on a training on a rowing machine with solicitation of the electrostimulated lower limbs and upper for a period of 3 months at the rate of 3 sessions of 30 minutes per week. The evaluations are composed of the measurement of maximum oxygen consumption, muscle and neurological parameters

Study Design

Study Type:
Interventional
Anticipated Enrollment :
35 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effects of Training on a Rower Assisted by Electrostimulation of Lower Limbs in Paraplegic Patients (FES-ROW)
Anticipated Study Start Date :
Apr 1, 2021
Anticipated Primary Completion Date :
Apr 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Rower

Single group of 35 traumatic paraplegic patients meeting the inclusion criteria will benefit from the FES-ROW protocol during 9 months

Device: Rower assisted by electrostimulation (FES-ROW)
Pre-inclusion visit Inclusion visit Phase 1 Rower-FES with lower limbs (Month 0 to Month 3: M0-M3): Training on a rower with solicitation of the electrostimulated lower limbs only for a period of 3 months at the rate of 3 sessions of 30 minutes per week Interim assessment visit at Month 3 (M3) Phase 2 Rower-FES with lower limbs + upper limbs (Month 3 to Month 6: M0-M6): Training on with solicitation of the electrostimulated lower and upper limbs for a period of 3 months at the rate of 3 sessions of 30 minutes per week Final assessment visit at Month 6 (M6) End of clinical research visit, 3 months after the end of training (Month 9, M9)

Outcome Measures

Primary Outcome Measures

  1. VO2 peak at 6 months (L/min) [6 months]

    Comparison of the maximum oxygen consumption (VO2 peak in L/min) measured during an incremental maximum stress test on a hand ergometer between the end of training on a rower (M6) and inclusion (M0).

Secondary Outcome Measures

  1. VO2 peak at 3 and 9 months (L/min) [9 months]

    Comparison of the maximum oxygen consumption (VO2 peak in L/min) measured during an incremental maximum stress test on a hand ergometer between the end of first training phase (M3) and inclusion (M0) and between the end of the study (M9) and inclusion (M0).

  2. First ventilatory threshold in the VO2max test at 0, 3, 6 and 9 months (L/min) [9 months]

    Comparison of the first ventilatory threshold (in L/min) in the VO2max test measured during an incremental maximum stress test on a hand ergometer between the end of first training phase (M3), the end of second phase (M6), the end of the study (M9) and inclusion (M0).

  3. Maximum electro-induced force at 0, 3, 6 and 9 months (Nm) [9 months]

    Comparison of maximum electro-induced force (in Newton) assessment with a device for measuring the force of the knee extensor muscles between the end of first training phase (M3), the end of second phase (M6), the end of the study (M9) and inclusion (M0).

  4. Thigh perimeter at 0, 3, 6 and 9 months (cm) [9 months]

    Comparison of thigh perimeter (in cm) assessment between the end of first training phase (M3), the end of second phase (M6), the end of the study (M9) and inclusion (M0).

  5. Maximum power at 0, 3, 6 and 9 months (Watts) [9 months]

    Comparison of the maximum power (in Watts) developed during the stress test on a hand ergometer between the end of first training phase (M3), the end of second phase (M6), the end of the study (M9) and inclusion (M0).

  6. Response to stimulation at 0, 3, 6 and 9 months (mA) [9 months]

    Comparison of the minimum threshold (Intensity in mA) of response to stimulation of the extensor muscles of the knee between the end of first training phase (M3), the end of second phase (M6), the end of the study (M9) and inclusion (M0).

  7. Assessment of spasticity at 0, 3, 6 and 9 months [9 months]

    Assessment of spasticity with Ashworth scale (rating from 0 to 4 which is the worst score) and Pendulum test (rating from 1 to 5 which is the worst score) between the end of first training phase (M3), the end of second phase (M6), the end of the study (M9) and inclusion (M0).

  8. Intensity of osteotendinous reflexes at 0, 3, 6 and 9 months [9 months]

    Comparison of the intensity of osteotendinous reflexes (Absent, normal and lively / diffuse / polykinetic) between the end of first training phase (M3), the end of second phase (M6), the end of the study (M9) and inclusion (M0).

  9. Self-assessment at 0, 3, 6 and 9 months [9 months]

    Self-assessment with Goal Attainment Scaling (GAS) between the end of first training phase (M3), the end of second phase (M6), the end of the study (M9) and inclusion (M0). GAS rating is divided in 5 levels: -2: Current level -1: Improvement 0: Expected level after action +1: Level better than expected +2: Maximum level expected

  10. ASIA (American Spinal Injury Association) score at 0, 6 and 9 months [9 months]

    Comparison between the end of the study following the remanence period (M9) and the inclusion (M0) and M6 of the parameters of ASIA (American Spinal Injury Association) score.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Paraplegia with traumatic origin

  • Spinal cord injury AIS (ASIA Impairment Scale) score A and B at least 12 months old

  • Patient having given written consent

  • Patient with social security scheme

  • Ability to obtain a leg extension with a 30-minute electrostimulation program

Exclusion Criteria:
  • Protected adults (person in guardianship, curators or legal protection)

  • Presence of contraindication criteria to carrying out a stress test or sustained physical activity decided by the doctor following the person with spinal cord injury.

  • Drug treatment with cardiovascular or antidepressant effect

  • Pressure sore

  • Other associated neurological pathologies (stroke, peripheral neuropathy, myopathy, head trauma, ...)

  • Affection of the shoulders of any etiology that could compromise the ability to use the rower.

  • Spasticity of the lower limbs: Modified Ashworth Scale (MAS) greater than or equal to 2/4 (specifically quadriceps / Hamstrings)

  • Participation in another study

Contacts and Locations

Locations

Site City State Country Postal Code
1 HIA Desgenettes Lyon Rhône France 69003
2 SSR Val Rosay UGECAM Saint-Didier-au-Mont-d'Or Rhône France 69370

Sponsors and Collaborators

  • UGECAM Rhône-Alpes
  • University of Franche-Comté
  • Hospices Civils de Lyon
  • University of Lyon

Investigators

  • Principal Investigator: Julie R Di Marco, M.D, UGECAM SSR Val Rosay

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
UGECAM Rhône-Alpes
ClinicalTrials.gov Identifier:
NCT04821635
Other Study ID Numbers:
  • 2020-1 (FESROW)
  • 2020-A00416-33
First Posted:
Mar 29, 2021
Last Update Posted:
Mar 29, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by UGECAM Rhône-Alpes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 29, 2021